Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.36B | 1.71B | 1.64B | 741.00M | 1.68B | 541.00M |
Gross Profit | 1.45B | 940.00M | 1.73B | 741.00M | 1.82B | 185.00M |
EBITDA | 1.86B | 2.32B | 2.12B | 1.16B | 1.60B | 823.00M |
Net Income | 1.46B | 1.52B | 1.52B | 600.00M | 1.57B | 484.00M |
Balance Sheet | ||||||
Total Assets | 29.07B | 28.25B | 23.80B | 22.40B | 20.84B | 16.20B |
Cash, Cash Equivalents and Short-Term Investments | 447.00M | 635.00M | 535.00M | 303.00M | 372.00M | 254.00M |
Total Debt | 0.00 | 13.76B | 11.94B | 12.32B | 11.14B | 8.55B |
Total Liabilities | 15.04B | 14.90B | 12.60B | 12.84B | 11.97B | 9.02B |
Stockholders Equity | 14.03B | 13.36B | 11.20B | 9.55B | 8.87B | 7.18B |
Cash Flow | ||||||
Free Cash Flow | 1.28B | 1.28B | 1.00B | 746.00M | 935.00M | 734.00M |
Operating Cash Flow | 1.28B | 1.28B | 1.00B | 746.00M | 935.00M | 734.00M |
Investing Cash Flow | -2.58B | -3.41B | -489.00M | -2.10B | -3.39B | -1.29B |
Financing Cash Flow | 1.29B | 2.42B | -284.00M | 1.21B | 2.62B | 707.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $2.27B | 12.02 | 11.66% | 8.61% | -6.29% | -15.46% | |
74 Outperform | $15.69B | 10.82 | 10.25% | 8.63% | 7.71% | -29.47% | |
74 Outperform | $5.78B | 10.54 | 19.65% | 6.48% | 28.32% | 13.63% | |
71 Outperform | $3.92B | 10.35 | 9.33% | 11.33% | 32.19% | -13.72% | |
68 Neutral | $17.69B | 11.82 | 10.30% | 3.73% | 9.66% | 0.42% | |
64 Neutral | $3.51B | 12.66 | 12.81% | 9.79% | -15.88% | -13.91% | |
58 Neutral | $5.02B | 22.97 | 3.39% | 15.62% | -8.32% | -65.56% |
On August 8, 2025, Ares Capital Corporation held a special meeting of stockholders where a proposal was approved to allow the company to sell or issue shares of its common stock at a price below its current net asset value per share, subject to certain limitations. This authorization, which includes a cap that the number of shares issued does not exceed 25% of its outstanding shares, will be effective for a twelve-month period ending on August 8, 2026.
On July 29, 2025, Ares Capital Corporation announced its financial results for the second quarter ending June 30, 2025, and declared a third quarter dividend of $0.48 per share, payable on September 30, 2025. The company reported a GAAP net income per share of $0.52 and a core EPS of $0.50, with net investment income totaling $342 million. The announcement reflects Ares Capital’s stable financial performance and commitment to returning value to its shareholders, maintaining its position as a strong player in the specialty finance sector.
On June 3, 2025, Ares Capital Corporation completed a transaction involving the issuance and sale of $750 million in 5.500% notes due 2030, under a Third Supplemental Indenture with U.S. Bank Trust Company. The proceeds from this offering are intended to repay certain outstanding debts, with the potential for reborrowing for general corporate purposes. The company also entered into an interest rate swap agreement to convert the fixed interest rate to a floating rate, enhancing its financial flexibility. This strategic financial maneuver aims to strengthen Ares Capital’s operational capacity and investment potential, while adhering to regulatory covenants and maintaining its market position.